The long-tailed macaque has lost a battle for its survival — but won one for scientific integrity, reports Mongabay’s Gerald Flynn. In early October, the IUCN, the global wildlife conservation authority, reaffirmed the species’ endangered status, rejecting an appeal by the U.S. National Association for Biomedical Research (NABR). The lobby group had argued that the listing impeded vaccine and drug development, since laboratories rely heavily on macaques for testing. The IUCN first elevated Macaca fascicularis from vulnerable to endangered in 2022, after evidence emerged that wild monkeys were being laundered into “captive-breeding” farms across Cambodia, Laos and Vietnam. Its latest review found that wild populations have fallen by as much as 70% over the past three decades. “I’m happy to see science prevail, but I’m not happy to see the long-tailed macaques endangered,” said Malene Friis Hansen of Aarhus University in Denmark, a co-author of the assessment. “That we’ve pushed such an adaptive synanthrope to this stage should be an eye-opener.” The COVID-19 pandemic intensified demand for macaques for medical testing. When China halted exports in 2020, Cambodia’s shipments nearly doubled. Reports soon surfaced that supposedly captive-bred macaques were, in fact, trapped in the wild and funneled through state-linked farms. U.S. prosecutors later alleged Cambodian officials’ complicity in the trade, though few have faced consequences. The industry, meanwhile, has prospered: wild monkeys can fetch a few hundred dollars, while laboratory buyers pay tens of thousands. The NABR insists the IUCN’s process was tainted by “emotive” language and conflicts of interest,…This article was originally published on Mongabay
Source link
The price of a monkey
